Results showed a consistent benefit in both patients with and those without heart failure.
AHA 2015 Complete Coverage
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.
Physicians may need to ask young adults about energy drink intake in emergency settings.
Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.
Mortality rate is higher among women with heart disease after discharge from the hospital.
Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.
Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.
Many women in the United States do not feel personally connected to the risk of heart disease.
Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Cerebral Small Vessel Disease More Common in Individuals With T1D vs General Population
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Risk for Congenital Heart Defects in Offspring of Mothers With Obesity
- Is the MiniMed 670G System Safe for Children With Type 1 Diabetes?
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Obesity Linked to Lower Gray Matter Brain Volume
- No Evidence for Health Benefits of Nonsugar Sweeteners